SGLT2 inhibitor-related AEs differ with heart failure and diabetes

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-024-69291-8
中图分类号
学科分类号
摘要
引用
收藏
页码:11 / 11
相关论文
共 50 条
  • [31] SGLT2 Inhibitor Prescribing Discrepancies in Patients with Diabetes Mellitus Type 2 and Heart Failure at an Academic Medical Center
    Hansen, Jessica
    Kulasa, Kristen
    Cavaiola, Tricia Santos
    DIABETES, 2023, 72
  • [32] Investigating SGLT2 Inhibitors in Heart Failure
    Mann, Liz
    Smith, Andrew
    US PHARMACIST, 2023, 48 (03) : 45 - 48
  • [33] Sotagliflozin, A Dual SGLT1 And SGLT2 Inhibitor, Reduces First And Subsequent Heart Failure-related Events In Patients Admitted For Worsening Heart Failure
    Pitt, Bertram
    Szarek, Michael
    Banks, Phillip
    Sun, Franklin
    Davies, Michael
    Bhatt, Deepak
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 683 - 684
  • [38] Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure
    Oh, Chang-Myung
    Cho, Sungsoo
    Jang, Ji-Yong
    Kim, Hyeongseok
    Chun, Sukyung
    Choi, Minkyung
    Park, Sangkyu
    Ko, Young-Guk
    KOREAN CIRCULATION JOURNAL, 2019, 49 (12) : 1183 - 1195
  • [39] EFFECTS OF THE SGLT2 INHIBITOR EMPAGLIFLOZIN ON VASCULAR FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE
    Kolwelter, Julie
    Bosch, Agnes
    Jung, Susanne
    Linz, Peter
    Kannenkeril, Dennis
    Nagel, Armin M.
    Ott, Christian
    Bramlage, Peter
    Uder, Michael
    Achenbach, Stephan
    Schmieder, Roland
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1806 - 1806
  • [40] SGLT2 inhibitor therapy in patients with advanced heart failure and reduced ejection fraction
    Nuzzi, Vincenzo
    Manca, Paolo
    Parisi, Francesca
    Madaudo, Cristina
    Sciacca, Sergio
    Cannizzo, Noemi
    Mule, Massimiliano
    Cipriani, Manlio G.
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (11)